GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (NAS:GENE) » Definitions » Sale Of Business

GENE (Genetic Technologies) Sale Of Business : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Genetic Technologies Sale Of Business?

Genetic Technologies's sale of business for the three months ended in Jun. 2024 was $0.00 Mil. It means Genetic Technologies gained $0.00 Mil from selling business. Genetic Technologies's sale of business for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Mar. 2024 ), Genetic Technologies gained the same money from selling business in Jun. 2024 ($0.00 Mil).

Genetic Technologies Sale Of Business Historical Data

The historical data trend for Genetic Technologies's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Sale Of Business Chart

Genetic Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genetic Technologies Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genetic Technologies Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies Sale Of Business Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (NAS:GENE) » Definitions » Sale Of Business
Comparable Companies
ASX:IBX ASX:LDX TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA LH SHSE:603259 DGX ICLR RVTY XPAR:BIM MEDP CRL
Traded in Other Exchanges
0A4N:UK DU8:Germany GTG:Australia
Address
60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Website
https://www.gtglabs.com
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.